SWM
GILD icon

Spire Wealth Management’s Gilead Sciences GILD Stock Holding History

Spire Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$593K Sell
4,696
-293
-6% -$38.6K 0.02% 512
2026
Q1 		$695K Buy
4,989
+188
+4% +$26.3K 0.02% 459
2025
Q4 		$589K Buy
4,801
+1,055
+28% +$128K 0.02% 505
2025
Q3 		$416K Sell
3,746
-925
-20% -$105K 0.01% 579
2025
Q2 		$518K Sell
4,671
-12,541
-73% -$1.33M 0.02% 500
2025
Q1 		$1.93M Buy
17,212
+1,652
+11% +$170K 0.06% 274
2024
Q4 		$1.44M Buy
15,560
+1,295
+9% +$117K 0.04% 314
2024
Q3 		$1.2M Buy
14,265
+5,479
+62% +$418K 0.04% 338
2024
Q2 		$603K Buy
8,786
+2,399
+38% +$160K 0.02% 452
2024
Q1 		$468K Sell
6,387
-952
-13% -$73.2K 0.01% 533
2023
Q4 		$641K Sell
7,339
-1,320
-15% -$103K 0.02% 456
2023
Q3 		$649K Buy
8,659
+469
+6% +$36.1K 0.02% 427
2023
Q2 		$631K Sell
8,190
-827
-9% -$66K 0.02% 441
2023
Q1 		$748K Buy
9,017
+91
+1% +$7.54K 0.03% 397
2022
Q4 		$766K Buy
8,926
+2,075
+30% +$164K 0.04% 274
2022
Q3 		$423K Sell
6,851
-1,165
-15% -$73.5K 0.03% 361
2022
Q2 		$495K Sell
8,016
-3,180
-28% -$197K 0.02% 475
2022
Q1 		$666K Sell
11,196
-2,216
-17% -$142K 0.02% 493
2021
Q4 		$974K Buy
13,412
+1,723
+15% +$119K 0.02% 477
2021
Q3 		$816K Sell
11,689
-308
-3% -$21.6K 0.02% 459
2021
Q2 		$826K Sell
11,997
-2,698
-18% -$180K 0.02% 478
2021
Q1 		$951K Buy
+14,695
New +$948K 0.03% 457

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Spire Wealth Management's GILD Position: Q2 2026 in Review

Spire Wealth Management reduced its Gilead Sciences (GILD) stake by 5.9% in Q2 2026, selling an estimated $38.6K and leaving 4,696 shares worth $593K. The position accounts for 0.02% of the portfolio, ranked #512.

Spire Wealth Management first reported a position in GILD in Q1 2021 and has held it in 22 quarters since. The position peaked at $1.93M in Q1 2025. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Spire Wealth Management held 4,696 shares of Gilead Sciences worth $593K as of Q2 2026.
  • Spire Wealth Management sold 293 Gilead Sciences shares in Q2 2026, an estimated $38.6K.
  • Gilead Sciences made up 0.02% of Spire Wealth Management's portfolio in Q2 2026, its #512 holding.
  • Spire Wealth Management first reported a position in Gilead Sciences in Q1 2021 and has held it in 22 quarters since.
  • Spire Wealth Management's Gilead Sciences position peaked at $1.93M in Q1 2025.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Spire Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.